Growth Metrics

Quantum-Si (QSIAW) Cost of Revenue (2020 - 2026)

Quantum-Si (QSIAW) reported Cost of Revenue of $184000.0 for Q1 2026, down 48.31% year-over-year from $356000.0 in Q1 2025, and down 44.07% on a QoQ basis from $329000.0 in Q4 2025.

Quantum-Si (QSIAW) has 6 years of Cost of Revenue data on file, last reported at $184000.0 in Q1 2026.

  • Quarterly Cost of Revenue fell 48.31% year-over-year to $184000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (down 31.67% YoY) and the FY2025 annual result came in at $1.3 million, down 12.0% from the prior year.
  • Cost of Revenue slipped to $184000.0 in Q1 2026 per QSIAW's latest filing, from $329000.0 in the prior quarter.
  • Across five years, Cost of Revenue topped out at $582000.0 in Q4 2024 and bottomed at $115000.0 in Q3 2023.
  • The 4-year median for Cost of Revenue is $240000.0 (2025), against an average of $270692.3.
  • The widest annual swing landed in 2024, when Cost of Revenue soared 265.22%; it then plunged 48.31% in 2026.
  • Tracing QSIAW's Cost of Revenue over 4 years: stood at $222000.0 in 2023, then soared by 162.16% to $582000.0 in 2024, then slumped by 43.47% to $329000.0 in 2025, then slumped by 44.07% to $184000.0 in 2026.
  • Per Business Quant, the three latest QSIAW Cost of Revenue figures stand at $184000.0 (Q1 2026), $329000.0 (Q4 2025), and $358000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.89 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.21 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.26 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.59 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 362.60 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 2.51 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 441.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 481.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 891.20 Mn
10 Quantum-Si - - 74,000.00 184,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 184,000.00
Mar 31, 2026 184,000.00
Dec 31, 2025 329,000.00
Dec 31, 2025 329,000.00
Sep 30, 2025 358,000.00
Sep 30, 2025 358,000.00
Jun 30, 2025 240,000.00
Jun 30, 2025 240,000.00
Mar 31, 2025 356,000.00
Mar 31, 2025 356,000.00
Dec 31, 2024 582,000.00
Dec 31, 2024 582,000.00
Sep 30, 2024 420,000.00
Sep 30, 2024 420,000.00
Jun 30, 2024 268,000.00
Jun 30, 2024 268,000.00
Mar 31, 2024 188,000.00
Mar 31, 2024 188,000.00
Dec 31, 2023 222,000.00
Dec 31, 2023 222,000.00
Sep 30, 2023 115,000.00
Sep 30, 2023 115,000.00
Jun 30, 2023 127,000.00
Jun 30, 2023 127,000.00
Mar 31, 2023 130,000.00
Mar 31, 2023 130,000.00
Dec 31, 2021 -2.72 Mn
Dec 31, 2021 -2.72 Mn
Sep 30, 2021 1.08 Mn
Sep 30, 2021 1.08 Mn
Jun 30, 2021 1.25 Mn
Jun 30, 2021 1.25 Mn
Dec 31, 2020 327,000.00
Dec 31, 2020 327,000.00
Sep 30, 2020 266,000.00
Sep 30, 2020 266,000.00
Jun 30, 2020 300,000.00
Jun 30, 2020 300,000.00